MetaCap

enGene Therapeutics (ENGN) News

NASDAQ: ENGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.74-0.02 (-1.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ENGN news summary

We found 1 recent headline mentioning enGene Therapeutics (ENGN): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ENGN is down 1.14% at $1.74. The most recent story, "Leerink Partners Upgrades enGene Therapeutics to Outperform from Market Perform", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest enGene Therapeutics headlines

Compare ENGN